Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin

Infect Immun. 2005 Jan;73(1):627-31. doi: 10.1128/IAI.73.1.627-631.2005.

Abstract

The vaccination of C3H/HeJ mice with Escherichia coli Dr fimbrial antigen reduced mortality associated with an experimental urinary tract infection due to a homologous strain bearing Dr adhesin. Immune sera with high titers of anti-Dr antibody inhibited bacterial binding to bladders and kidneys but did not affect the rate of renal colonization.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adhesins, Escherichia coli / physiology*
  • Animals
  • Chronic Disease
  • Escherichia coli Infections / prevention & control*
  • Escherichia coli Proteins / immunology*
  • Female
  • Fimbriae Proteins / immunology*
  • Mice
  • Mice, Inbred C3H
  • Urinary Tract Infections / prevention & control*
  • Vaccination

Substances

  • Adhesins, Escherichia coli
  • Escherichia coli Proteins
  • Fimbriae Proteins